| Financial Year |
March 31 2023 |
| Monetary Funds |
410,519,510.89 |
| Held-for-trading Financial Assets |
340,000,000.00 |
| Notes Receivable |
1,000,000.00 |
| Accounts Receivable |
30,397,727.36 |
| Advances to Suppliers |
16,711,821.99 |
| Other Receivables |
2,261,140.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
154,769,528.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
886,382.65 |
| Total Current Assets |
956,546,111.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
49,723,689.43 |
| Investment Properties |
28,588,284.73 |
| Fixed Assetes |
160,094,334.31 |
| Under-construction Projects |
9,748,040.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,281,016.06 |
| R&D expenses |
-- |
| Goodwill |
2,051,541.06 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,537,610.79 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
326,392,014.43 |
| Total Assets |
1,282,938,126.23 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
90,711,364.63 |
| Accounts Received In Advance |
1,815,591.50 |
| Employee Compensation Payable |
14,251,756.05 |
| Taxes Payable |
15,107,202.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,223,280.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,048,900.50 |
| Other Current Liabilities |
1,562,566.38 |
| Sub-Total of Current Liabilities |
154,651,355.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,261,831.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,159,532.29 |
| Total Liabilities |
173,810,887.79 |
| Paid-In Capital(Or Share Stock) |
288,000,000.00 |
| Capital Surplus |
175,534,430.38 |
| Surplus Reserve |
78,236,335.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
567,356,472.97 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,109,127,238.44 |
| Owner's Equity（Stockholder's Equity） |
1,109,127,238.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,282,938,126.23 |
